Regulus filed a solicitation/recommendation statement on Schedule 14D-9 with the SEC, which includes, among other things, the recommendation of Regulus’s board of directors that Regulus’s stockholders ...

For the estimated 2.8 million people 1 living with multiple sclerosis (MS) worldwide, diagnosis is life-altering and can be overwhelming. The symptoms, including loss of vision, movement and sensation ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

The world has entered a new era of cancer care – and as scientific advances have dramatically improved outcomes, patients are more informed and empowered than ever to be their own treatment advocates.

Learn about the launch of our new state-of-the-art space, built to accelerate innovation from the inside out and provide new solutions for employees, partners and ultimately, our patients. On a crisp ...

In today's rapidly evolving healthcare landscape, there is a profound shift in how patients approach their cancer diagnosis and treatment. Novartis has been committed to extending and improving lives ...

Elevated Lp(a) is a unique and genetically determined condition that can increase risk for ASCVD 1. Read on to learn more about patient populations at risk. May 19, 2025 Elevated lipoprotein(a), also ...

• Applications are now being accepted, with $500,000 in grants to be awarded to projects focused on improving health equity in Canada Montreal, Quebec, May 14, 2025 – Novartis Pharmaceuticals Canada ...

Fabhalta APPULSE-PNH full results build on Phase III program, reporting new data from expanded PNH population in adults switching from anti-C5 Ianalumab Phase II data in immune thrombocytopenia and ...

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...

At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...